Shares of Illumina Inc. ILMN rose 2.33% to $86.62 Friday, on what proved to be an all-around positive trading session for the ...

Shares of Illumina Inc. ILMN slipped 1.79% to $94.05 Wednesday, on what proved to be an all-around mixed trading session for the stock market ... which the company reached on November 5th.

Illumina stock skidded Tuesday after China signaled it would ban the company from importing its gene-mapping products.

What a brutal six months it’s been for Illumina. The stock has dropped 30.9% and now trades at $84.65, rattling many shareholders. This may have investors wondering how to approach the situation.

Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...

The company's stock has been the subject of intense ... However, some analysts estimate that the impact of competition on Illumina's growth could be limited to less than 100 basis points ...

Competitive Landscape: Illumina faces increasing competition from companies like Pacific Biosciences (NASDAQ ... You can also see if ILMN appears on our undervalued or overvalued stock lists. These ...

The company's stock has been the subject of intense scrutiny by analysts ... However, some analysts estimate that the impact of competition on Illumina's growth could be limited to less than 100 basis ...